A phase II study to evaluate the need for > two doses of nivolumab plus ipilimumab combination (combo) immunotherapy Meeting Abstract

  

Authors:	Postow, M. A.; Goldman, D. A.; Shoushtari, A. N.; Warner, A. B.; Callahan, M. K.; Momtaz, P.; Naito, E.; Eton, O.; Nair, S.; Wolchok, J. D.; Panageas, K.; Chapman, P. B.
Abstract Title:	A phase II study to evaluate the need for > two doses of nivolumab plus ipilimumab combination (combo) immunotherapy
Meeting Title:	56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	38
Issue:	15 Suppl.
Meeting Dates:	2020 May 29-31
Meeting Location:	Virtual Conference
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2020-05-20
Language:	English
ACCESSION:	WOS:000560368300107
PROVIDER:	wos
DOI:	10.1200/JCO.2020.38.15_suppl.10003
Notes:	Meeting Abstract: 10003 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/172965